Certior Financial Group’s Gilead Sciences GILD Stock Holding History

Certior Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506K	Buy	4,007 +72	+2%	+$9.49K	0.28%	71
2026 Q1	$548K	Buy	3,935 +41	+1%	+$5.74K	0.35%	54
2025 Q4	$478K	Buy	3,894 +250	+7%	+$30.4K	0.32%	59
2025 Q3	$404K	Sell	3,644 -2	-0.1%	-$227	0.27%	81
2025 Q2	$404K	Buy	3,646 +6	+0.2%	+$639	0.3%	74
2025 Q1	$408K	Buy	3,640 +68	+2%	+$7.02K	0.33%	69
2024 Q4	$330K	Buy	+3,572	New	+$322K	0.29%	91

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Certior Financial Group's GILD Position: Q2 2026 in Review

Certior Financial Group increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $9.49K and bringing the position to 4,007 shares worth $506K. The position accounts for 0.28% of the portfolio, ranked #71.

Certior Financial Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $548K in Q1 2026. 890 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Certior Financial Group held 4,007 shares of Gilead Sciences worth $506K as of Q2 2026.
Certior Financial Group bought 72 Gilead Sciences shares in Q2 2026, an estimated $9.49K.
Gilead Sciences made up 0.28% of Certior Financial Group's portfolio in Q2 2026, its #71 holding.
Certior Financial Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Certior Financial Group's Gilead Sciences position peaked at $548K in Q1 2026.
890 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Certior Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.